Roche aims to expand in China despite reducing costs elsewhere

09/8/2010 | Wall Street Journal, The

Roche Holding intends to expand drug research and development, diagnostic operations and its workforce in China during the next several years, even though the company is cutting costs elsewhere. The move comes as the Chinese government pledges a $125 billion investment to improve the country's health care infrastructure.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY